Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Healthcare Industry News BCAL Diagnostics set to begin trading on ASX after raising $7.3m in IPO BCAL Diagnostics is set to list on the Australian Securities Exchange (ASX) after an initial public offering that… byPallavi MadhirajuJuly 21, 2021
